Anemias:
Indications for: LUPRON DEPOT-3 MONTH 11.25mg
Preoperative improvement of patients with anemia due to uterine leiomyomata (fibroids), with iron therapy if iron therapy alone is inadequate.
Adult Dosage:
Give as single IM inj into gluteal area, anterior thigh or deltoid. ≥18yrs: 11.25mg once (3-month course). Do not split doses.
Children Dosage:
<18yrs: not established.
LUPRON DEPOT-3 MONTH 11.25mg Contraindications:
Undiagnosed abnormal vaginal bleeding. Pregnancy. Nursing mothers. When coadministered with norethindrone acetate, its contraindications also apply to this combination regimen.
LUPRON DEPOT-3 MONTH 11.25mg Warnings/Precautions:
Exclude pregnancy prior to initiation; advise to use nonhormonal contraception during therapy; discontinue if pregnancy occurs. Risk factors for decreased bone mineral density (eg, chronic alcohol, tobacco, family history of osteoporosis, anticonvulsants, corticosteroids); consider concomitant norethindrone acetate and supplemental calcium in endometriosis; assess BMD before retreatment. History of depression. Missing successive doses may cause breakthrough bleeding or ovulation. Elderly.
See Also:
LUPRON DEPOT-3 MONTH 11.25mg Classification:
GnRH analogue.
Adverse Reactions:
Hot flashes/sweats, headache, decreased libido, depression/emotional lability, dizziness, nausea/vomiting, pain, weight gain/loss, vaginitis, amenorrhea, acne, skin reactions; bone density loss, convulsions, hypersensitivity reactions; rare: anaphylaxis, asthma.
How Supplied:
Kit—1 (prefilled dual-chamber syringe w. supplies)
Endometriosis:
Indications for: LUPRON DEPOT-3 MONTH 11.25mg
Endometriosis management, including pain relief and reduction of endometriotic lesions. With norethindrone acetate: for initial management and recurrent symptoms.
Adult Dosage:
Give as single IM inj into gluteal area, anterior thigh or deltoid; rotate inj sites. ≥18yrs: 11.25mg once every 3 months; treat for up to 6 months. May repeat one 6-month cycle; give with norethindrone acetate 5mg daily when retreating (do not use leuprolide alone for retreatment). Max total treatment: 12 months. Do not split doses.
Children Dosage:
<18yrs: not established.
LUPRON DEPOT-3 MONTH 11.25mg Contraindications:
Undiagnosed abnormal vaginal bleeding. Pregnancy. Nursing mothers. When coadministered with norethindrone acetate, its contraindications also apply to this combination regimen.
LUPRON DEPOT-3 MONTH 11.25mg Warnings/Precautions:
Exclude pregnancy prior to initiation; advise to use nonhormonal contraception during therapy; discontinue if pregnancy occurs. Risk factors for decreased bone mineral density (eg, chronic alcohol, tobacco, family history of osteoporosis, anticonvulsants, corticosteroids); consider concomitant norethindrone acetate and supplemental calcium in endometriosis; assess BMD before retreatment. History of depression. Missing successive doses may cause breakthrough bleeding or ovulation. Elderly.
See Also:
LUPRON DEPOT-3 MONTH 11.25mg Classification:
GnRH analogue.
Adverse Reactions:
Hot flashes/sweats, headache, decreased libido, depression/emotional lability, dizziness, nausea/vomiting, pain, weight gain/loss, vaginitis, amenorrhea, acne, skin reactions; bone density loss, convulsions, hypersensitivity reactions; rare: anaphylaxis, asthma.
How Supplied:
Kit—1 (prefilled dual-chamber syringe w. supplies)
Miscellaneous Ob/Gyn conditions:
Indications for: LUPRON DEPOT-3 MONTH 11.25mg
Preoperative improvement of patients with anemia due to uterine leiomyomata (fibroids), with iron therapy if iron therapy alone is inadequate.
Adult Dosage:
Give as single IM inj into gluteal area, anterior thigh or deltoid. ≥18yrs: 11.25mg once (3-month course). Do not split doses.
Children Dosage:
<18yrs: not established.
LUPRON DEPOT-3 MONTH 11.25mg Contraindications:
Undiagnosed abnormal vaginal bleeding. Pregnancy. Nursing mothers. When coadministered with norethindrone acetate, its contraindications also apply to this combination regimen.
LUPRON DEPOT-3 MONTH 11.25mg Warnings/Precautions:
Exclude pregnancy prior to initiation; advise to use nonhormonal contraception during therapy; discontinue if pregnancy occurs. Risk factors for decreased bone mineral density (eg, chronic alcohol, tobacco, family history of osteoporosis, anticonvulsants, corticosteroids); consider concomitant norethindrone acetate and supplemental calcium in endometriosis; assess BMD before retreatment. History of depression. Missing successive doses may cause breakthrough bleeding or ovulation. Elderly.
See Also:
LUPRON DEPOT-3 MONTH 11.25mg Classification:
GnRH analogue.
Adverse Reactions:
Hot flashes/sweats, headache, decreased libido, depression/emotional lability, dizziness, nausea/vomiting, pain, weight gain/loss, vaginitis, amenorrhea, acne, skin reactions; bone density loss, convulsions, hypersensitivity reactions; rare: anaphylaxis, asthma.
How Supplied:
Kit—1 (prefilled dual-chamber syringe w. supplies)
